These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 15301960)

  • 1. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery.
    Lo MC; Aulabaugh A; Jin G; Cowling R; Bard J; Malamas M; Ellestad G
    Anal Biochem; 2004 Sep; 332(1):153-9. PubMed ID: 15301960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ligand affinity of proteins measured by isothermal denaturation kinetics.
    Epps DE; Sarver RW; Rogers JM; Herberg JT; Tomich PK
    Anal Biochem; 2001 May; 292(1):40-50. PubMed ID: 11319816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of proteins by ligand binding: application to drug screening and determination of unfolding energetics.
    Waldron TT; Murphy KP
    Biochemistry; 2003 May; 42(17):5058-64. PubMed ID: 12718549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors.
    Mayhood TW; Windsor WT
    Anal Biochem; 2005 Oct; 345(2):187-97. PubMed ID: 16140252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic analysis of ligand-induced changes in protein thermal unfolding applied to high-throughput determination of ligand affinities with extrinsic fluorescent dyes.
    Layton CJ; Hellinga HW
    Biochemistry; 2010 Dec; 49(51):10831-41. PubMed ID: 21050007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-based thermal shift assays.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):389-402. PubMed ID: 20597025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for ligands using a generic and high-throughput light-scattering-based assay.
    Senisterra GA; Markin E; Yamazaki K; Hui R; Vedadi M; Awrey DE
    J Biomol Screen; 2006 Dec; 11(8):940-8. PubMed ID: 17092916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay.
    Xu W; Chen G; Liew OW; Zuo Z; Jiang H; Zhu W
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3188-92. PubMed ID: 19447035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-quenching screening of protein kinase C ligands with an environmentally sensitive fluorophore.
    Nomura W; Ohashi N; Okuda Y; Narumi T; Ikura T; Ito N; Tamamura H
    Bioconjug Chem; 2011 May; 22(5):923-30. PubMed ID: 21434694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging the contribution of thermodynamics in drug discovery with the help of fluorescence-based thermal shift assays.
    Hau JC; Fontana P; Zimmermann C; De Pover A; Erdmann D; Chène P
    J Biomol Screen; 2011 Jun; 16(5):552-6. PubMed ID: 21441415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability.
    Niesen FH; Berglund H; Vedadi M
    Nat Protoc; 2007; 2(9):2212-21. PubMed ID: 17853878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adopting a practical statistical approach for evaluating assay agreement in drug discovery.
    Sun D; Whitty A; Papadatos J; Newman M; Donnelly J; Bowes S; Josiah S
    J Biomol Screen; 2005 Aug; 10(5):508-16. PubMed ID: 16093560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ligand protonation on virtual screening against beta-secretase (BACE1).
    Polgar T; Magyar C; Simon I; Keserü GM
    J Chem Inf Model; 2007; 47(6):2366-73. PubMed ID: 17944457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand.
    Huang X
    J Biomol Screen; 2003 Feb; 8(1):34-8. PubMed ID: 12854996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor.
    Matulis D; Kranz JK; Salemme FR; Todd MJ
    Biochemistry; 2005 Apr; 44(13):5258-66. PubMed ID: 15794662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyramine fragment binding to BACE-1.
    Kuglstatter A; Stahl M; Peters JU; Huber W; Stihle M; Schlatter D; Benz J; Ruf A; Roth D; Enderle T; Hennig M
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1304-7. PubMed ID: 18226904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
    Kornacker MG; Lai Z; Witmer M; Ma J; Hendrick J; Lee VG; Riexinger DJ; Mapelli C; Metzler W; Copeland RA
    Biochemistry; 2005 Aug; 44(34):11567-73. PubMed ID: 16114893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acetonitrile on Cynara cardunculus L. cardosin A stability.
    Shnyrova AV; Oliveira CS; Sarmento AC; Barros MT; Zhadan GG; Roig MG; Shnyrov VL
    Int J Biol Macromol; 2006 Nov; 39(4-5):273-9. PubMed ID: 16712922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists.
    Habig M; Blechschmidt A; Dressler S; Hess B; Patel V; Billich A; Ostermeier C; Beer D; Klumpp M
    J Biomol Screen; 2009 Jul; 14(6):679-89. PubMed ID: 19470716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.